Healthier Together: New Alzheimer’s disease warning signs to look out for
A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...
Why could Ozempic play a role in reducing the risk of Alzheimer's disease?
Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...
10 healthy brain habits to consider for Alzheimer’s disease awareness month
Here are 10 healthy habits for our brain suggested by the Alzheimer’s Association. Challenge your mind. Learn something new ...
Structural analysis shows Alzheimer's disease mutation produces 'cottonwool' structures in the brain
An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...
New drug targets for Alzheimer's identified from cerebrospinal fluid
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
Brain Autopsies Reveal a Potential New Culprit Behind Alzheimer's
University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...
Alzheimer's Disease Month - Helping Those Living with the Disease
November is National Alzheimer’s Disease Month, and it’s also Caretaker Month. These two things often go hand-in-hand, but ...
‘The Unicorn' at UNTHSC is a gamechanger, say Alzheimer's researchers
Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...
New Target for Alzheimer’s: Researchers Discover Enzyme Behind Tau Protein Build-Up
Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
The Lancet20h
Amyloid-lowering treatment in Alzheimer's disease
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...